USPTO 2015–2025 USPTO PatentsView US Corporation

Natera, Inc.

USPTO PatentsView assignee record - 122 granted patents across 13 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

122

Total patents granted

CPC technology areas

18.3

Avg claims per patent

+207%

5-year filing velocity

The verdict

Natera holds 122 US patents across 13 technology areas, rank #3,102 of 50,000 tracked assignees.

#3,102
of 50,000 US assignees by volume: Top 19%
by Innovation Score (47.0/100): 18.3
avg claims per patent: +207%
filing velocity, last 5 yrs

Portfolio overview

Natera, Inc. has been granted 122 US utility patents between 2015 and 2025, placing Natera, Inc. at rank #3,102 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.3 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Natera, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Natera sits between Irdeto B.v. (122 patents, rank #3,098) and Saint-gobain Isover (122 patents, rank #3,106) - the closest US assignees by grant volume. The composite Innovation Score of 47.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 92 grants, compared with 30 in the 2015–2019 window, a +207% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Natera, Inc.'s 18.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Natera, Inc. against peers pursuing similar technology classes.

Irdeto B V

122
MAN Energy Soluti…

122
Mitsubishi Heavy…

122
Morpho

122
Nextnav

122
Oiles

122
Quarkstar

122
Saint-gobain Isov…

122
Natera ◀

122

What this shows Natera holds 122 patents at rank #3,102, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Natera

By rank, the assignees closest to #3,102 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Natera's primary technology class.

Natera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Natera, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	1.6%
2016	5	4.1%
2017	3	2.5%
2018	8	6.6%
2019	12	9.8%
2020	17	13.9%
2021	17	13.9%
2022	32	26.2%
2023	3	2.5%
2024	11	9.0%
2025	12	9.8%

Which technologies does Natera, Inc. patent most?

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 95

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 56

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 18

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 16

G16Z - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR 9

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 7

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 2

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 2

B04B - CENTRIFUGES 2

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 2

B01D - SEPARATION 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 2

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 2

Top 13 of 13 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Focused

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#3,102

Across all tracked assignees

Innovation Score

47.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Natera, Inc. hold?

Natera, Inc. holds 122 US granted patents filed between 2015 and 2025, spanning 13 technology areas.

What is Natera, Inc.'s Innovation Score?

Natera, Inc. has an Innovation Score of 47.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Natera, Inc. focus on?

Natera, Inc.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 95 patents. The company has filed patents in 13 CPC subclasses total.

Is Natera, Inc.'s patent filing rate increasing or decreasing?

Natera, Inc.'s recent filing velocity is +207% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Natera, Inc.'s patents?

Natera, Inc.'s patents average 18.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the Natera, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Natera's 122 grants land it in the top 19% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Natera ranks #3,102 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12Q - see who else leads that technology area. C12Q leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.